UroGen Pharma offers the UroGen Support program to assist patients while taking Jelmyto (Table).
This program makes the access, reimbursement, and coordination process as simple as possible for you and your patients by providing support through territory business managers, field reimbursement managers, and clinical nurse educators. UroGen Support is committed to helping patients access Jelmyto through the UroGen Support Copay Program and the UroGen Support Patient Assistance Program.
Patients with commercial health insurance may be eligible to receive Jelmyto for as little as $50 per dose with a maximum benefit of $4000 per dose up to $13,800 per year. Patients may be eligible if they:
Click here to enroll your patient in the UroGen Support Copay Program.
Uninsured patients may be able to receive Jelmyto through the UroGen Support Patient Assistance Program. Patients may be eligible if they:
Click here to enroll your patient in the UroGen Support Patient Assistance Program.
Have you encountered a problem with a URL (link) on this page not loading correctly or is displaying an error message?
Help us fix it! Report broken links here.
Report Broken Links
Submit